MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported preliminary and unaudited financial results for the three-month period ...

TORONTO , Sept. 17 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that Steve West , President of MDS Nordion, ...

The Notice has been filed with the Ontario Superior Court of Justice, and names MDS Inc., Danaher Corporation and DH Technologies Development PTE Ltd. The Notice relates to the sale of MDS Analytical ...

MDS Inc, parent company of radioisotope producer MDS Nordion, is to write off the value of its assets in the abandoned MAPLE reactor project. MDS Inc, parent company of radioisotope producer MDS ...

The offer is not conditional upon any minimum number of Common Shares being deposited; however, the offer is subject to certain other conditions. Full particulars of the terms and conditions of the ...

Health sciences giant MDS Inc. says it will record a special gain of 3 cents a share in the third quarter to reflect a series of transactions in its life sciences division. Toronto-based MDS has about ...

Canadian life sciences company MDS Inc is not out the woods yet with MDS Pharma Services, the contract research organisation (CRO) still feeling the reverberations from US concerns over bioequivalence ...

MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has completed the divestiture of its Central Labs operations to ...

Based on preliminary results, MDS Inc. ("MDS") will accept for purchase and cancellation 52,941,176 common shares in the capital of MDS (the "Common Shares") at a purchase price of US$8.50 per Common ...

OTTAWA, June 14 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health sciences market, today reported financial results and filed its unaudited ...

Life-sciences company MDS Inc. says it expects to notch up $28 million in charges as it cuts 210 jobs and records an asset-impairment charge related to the troubled MDS Pharma Services business. The ...

A big gain from the sale of its diagnostics division pushed MDS Inc. to a profit of $736 million US in the second quarter. The Toronto-based life sciences company said the gain was $792 million US ...